As a PhD student at Vall d’Hebron Research Institute (VHIR) I was trained in the biomarkers field and clinical stroke studies, which gave me a solid understanding of the disease from a clinical perspective. After I moved to the United States for a Postdoctoral position at the Massachusetts General Hospital in a world-leading laboratory recognized for their experimental studies in cerebral ischemia (Neuroprotection Research Laboratory-MGH), which offered me the opportunity to extend my experience at a more basic and experimental level. I obtained a Miguel Servet position in 2010 from the Spanish National Institute of Health and Research Agency (Instituto Carlos III), and since February 2016 I hold a Tenure position at VHIR as Principal Investigator and since 2017 I am the head of the Neurovascular Research Laboratory. The main focus of my research is the search of new therapies for stroke patients based on neurorepair strategies with specific emphasis on the role of angio-vasculogenesis using nanomedicine and cell-therapy approaches for regenerative medicine. This has allowed me to obtain independent funding as PI from national agencies, Euronanomed program and private foundations, to supervise and guide PhD Students, Post-doctoral researchers, and establish national and International collaborations with other PIs in the neuroscience, regenerative medicine and nanotechnology fields. I do have the research accreditation of Associate Professor from AQU. My group has a distinction of Consolidated Research Group by AGAUR (2017SGR 1427) and belongs to the Spanish Cooperative Network for Research in Cerebrovascular Diseases (RICORS-2022).
